These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8004938)

  • 21. A microcomputer program for exact and asymptotic analysis of several 2 x 2 tables.
    Vollset SE; Hirji KF
    Epidemiology; 1991 May; 2(3):217-20. PubMed ID: 2054406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of group sequential stopping boundaries to evaluate the treatment effect of an experimental agent across a range of biomarker expression.
    Holmgren E
    Contemp Clin Trials; 2017 Dec; 63():13-18. PubMed ID: 28245996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of the triangular test to phase II cancer clinical trials.
    Bellissant E; Benichou J; Chastang C
    Stat Med; 1990 Aug; 9(8):907-17. PubMed ID: 2218193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An improved approximation for calculation of confidence intervals after a sequential clinical trial.
    Facey KM; Whitehead J
    Stat Med; 1990 Nov; 9(11):1277-85. PubMed ID: 2277878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A note on P-values under group sequential testing and nonproportional hazards.
    Gillen DL; Emerson SS
    Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A composite design for transition from a preliminary to a full-scale study.
    Lachin JM; Younes N
    Stat Med; 2007 Nov; 26(27):5014-32. PubMed ID: 17577245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A practical simulation method to calculate sample size of group sequential trials for time-to-event data under exponential and Weibull distribution.
    Jiang Z; Wang L; Li C; Xia J; Jia H
    PLoS One; 2012; 7(9):e44013. PubMed ID: 22957040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group-sequential methods for adaptive seamless phase II/III clinical trials.
    Stallard N
    J Biopharm Stat; 2011 Jul; 21(4):787-801. PubMed ID: 21516569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STEIN: A simple toxicity and efficacy interval design for seamless phase I/II clinical trials.
    Lin R; Yin G
    Stat Med; 2017 Nov; 36(26):4106-4120. PubMed ID: 28786138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-arm phase II trial design under parametric cure models.
    Wu J
    Pharm Stat; 2015; 14(3):226-32. PubMed ID: 25846141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing phase II studies in cancer with time-to-event endpoints.
    Owzar K; Jung SH
    Clin Trials; 2008; 5(3):209-21. PubMed ID: 18559409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of phase II clinical trials in haematology and oncology: comparison of the triangular test to the usual methods.
    Benichou J; Bellissant E; Chastang C
    Stat Med; 1991 Jun; 10(6):989; discussion 989-90. PubMed ID: 1876789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Group Sequential Design for Randomized Phase III Trials under the Weibull Model.
    Wu J; Xiong X
    J Biopharm Stat; 2015; 25(6):1190-205. PubMed ID: 25322440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microcomputer-assisted multivariate survival data analysis using Cox's proportional hazards regression model.
    Campos-Filho N; Franco EL
    Comput Methods Programs Biomed; 1990 Feb; 31(2):81-7. PubMed ID: 2335079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-stage designs for phase II cancer trials with ordinal responses.
    Stallard N; Cockey L
    Contemp Clin Trials; 2008 Nov; 29(6):896-904. PubMed ID: 18703164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exact estimates for a rate ratio.
    Martin DO; Austin H
    Epidemiology; 1996 Jan; 7(1):29-33. PubMed ID: 8664397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluxplus, a microcomputer program for interactive calculation of 'in vitro' solute fluxes, uptakes and accumulations in studies of intestinal transport.
    Díaz M; Cozzi S
    Comput Methods Programs Biomed; 1991 Apr; 34(4):263-71. PubMed ID: 1873994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Bayesian group sequential design for a multiple arm randomized clinical trial.
    Rosner GL; Berry DA
    Stat Med; 1995 Feb; 14(4):381-94. PubMed ID: 7746978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COSIFIT: an interactive program for simultaneous multioscillator cosinor analysis of time-series data.
    Teicher MH; Barber NI
    Comput Biomed Res; 1990 Jun; 23(3):283-95. PubMed ID: 2350963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.